The INAHTA Board of Directors is composed of a diverse representation of the INAHTA membership.  The Board is responsible for guiding the overall direction and activities of the Network and Secretariat toward the implementation of the INAHTA Strategic Plan. The members of the Board are representatives of an INAHTA member agency and they are elected by the membership for 2-year terms.

INAHTA Board Members

Prof. Tracy Merlin, AHTA, Australia, Chair (2020-2022)
Dr. Michelle Mujoomdar, CADTH, Canada, Vice Chair (2020-2022)

Dr. Matthias Perleth, G-BA, Germany, Treasurer (2020-2022)
Chantal Guilhaume, PharmD, HAS, France, Director (2019-2021)
Dr. Li Ying (Grace) Huang, CDE, Taiwan, Republic of China, Director (2019-2021)
Dr. Mouna Jameleddine, INEAS, Tunisia, Director (2018-2022)
Karen Macpherson, HIS, UK, Director (2020-2022)
Dr. Sophie Söderholm Werkö, SBU, Sweden, Past Chair (2020-2022) (Ex officio)
-> View Board member profiles below



Prof. Tracy Merlin, AHTA, Australia
Chair (2020-2022)

View profile



Dr. Michelle Mujoomdar, CADTH, Canada
Vice Chair (2020-2022)

View profile


Dr. Matthias Perleth, G-BA, Germany
Treasurer (2018-2022)

View profile


Chantal Guilhaume, PharmD, HAS, France
Director (2019-2021)
View profile


Dr. Li Ying (Grace) Huang, CDE, Taiwan, Republic of China
Director (2019-2021)
View profile


Dr. Mouna Jameleddine, INEAS, Tunisia
Director (2018-2022)

View profile


Karen Macpherson, HIS, UK
Director (2020-2022)

View profile



Dr. Sophie Söderholm Werkö, SBU, Sweden
Past Chair (2020-2022)
(Ex officio)
View profile